Grace Therapeutics intends to use the upfront net proceeds from the private placement for general corporate purposes and to fund pre-commercial development of GTx-104, a clinical stage, novel, ...
VANCOUVER, BC / ACCESS Newswire / February 10, 2025 / Primary Hydrogen Corp. (TSXV:HDRO)(FRA:83W0)(OTCQB:HNATF) (the "Company" or "Primary"), a leading junior exploration company focused on unlocking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback